Nuclera Expands Global Footprint with New Distribution Partnerships Across APAC and the Middle East

May 6, 2025

At Nuclera, we are excited to announce that we have established a distribution network across the Asia-Pacific (APAC) region and the Middle East. This milestone marks a major advancement in our global commercial strategy, allowing us to provide localized technical support and easier access to our eProtein Discovery™ System for customers in key international markets.

In response to the rapidly growing demand for our innovative system, we have partnered with seven leading channel partners: MineBio Life Sciences Ltd (China), Kiko Tech Co., Ltd (Japan), CHAYON Laboratories, Inc. (South Korea), Sciencewerke Pte Ltd (Singapore), Cold Spring Biotech (Taiwan), and Yair Or Technologies Ltd (Israel).

These partnerships come on the heels of a major enhancement to our eProtein Discovery System, which now supports workflows for both membrane and soluble protein discovery. Proteins represent 95% of drug targets designed to combat disease, so developing efficient, reliable ways to express soluble and active proteins is critical for accelerating drug discovery. With our system, researchers can rapidly and scalably access high-quality proteins across both cell-free and cell-based expression methods.

We are proud that our system is already being installed at leading academic institutions and within a contract research organization (CRO), showing how much value researchers are finding in eProtein Discovery.

As our CEO and co-founder, Dr Michael Chen, said: “Expanding into APAC and the Middle East, in response to growing global demand, demonstrates the potential of eProtein Discovery to revolutionize the way proteins are made. Testament to the growing demand are installations of eProtein Discovery at leading pharma and academic institutions and the first installation of our system within a CRO. We have partnered with established companies across key markets to enable specialized local support for our customers, enabling them to make proteins for drug discovery more efficiently and effectively.”

Our Chief Commercial Officer, Joseph Bertelsen, added: “We are excited to have extended our reach to the Middle East and Asia through partnering with key distributors Yair Or Technologies, Minebio, Chayon Laboratories, Kiko-Tech, ScienceWerke, and Cold Spring Biotech. Establishing these distribution channels supports our goal of global expansion and comes at a pivotal time for the Company as we are focused on ramping-up commercially following the successful close of our series C fundraising round.”

We believe this expansion is a key step in our mission to empower scientists around the world with faster, more efficient protein expression solutions.

Get in touch with a Nuclera distributor in your region:

China
Website: MineBio Life Sciences Ltd

Address: 7th Floor, Building 1, No.388, Shengrong Road, Pudong New District, Shanghai, China

Email: [email protected]

Phone: +86-021-51769110

Japan

Website: Kiko Tech
Contact person: Shigenobu Fukushima, Senior Director, Business Development

Email: [email protected]

Singapore

Website: Sciencewerke

South Korea

Website: CHAYON Laboratories, Inc.